Fungaemia due to rare yeasts in a tertiary care university centre within 18 years

Alp Ş., Gulmez D., Ayaz C., Arikan-Akdagli S., Akova M.

MYCOSES, vol.63, no.5, pp.488-493, 2020 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 63 Issue: 5
  • Publication Date: 2020
  • Doi Number: 10.1111/myc.13072
  • Journal Name: MYCOSES
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database
  • Page Numbers: pp.488-493
  • Keywords: amphotericin B, antifungal resistance, antifungal treatment, azoles, breakthrough fungaemia, echinocandins, fungaemia, rare yeast, INFECTIOUS-DISEASES SOCIETY, CLINICAL-PRACTICE GUIDELINE, SAPROCHAETE-CAPITATA, HEMATOLOGICAL MALIGNANCIES, RHODOTORULA-MUCILAGINOSA, CANDIDIASIS, MANAGEMENT, DIAGNOSIS, CANCER, UPDATE
  • Hacettepe University Affiliated: Yes

Abstract

Background Fungaemia due to rare yeasts has been recognised as an emerging, clinically relevant, but less investigated condition. Intrinsic resistance or reduced susceptibility of these species to echinocandins or fluconazole remains as a challenge in empirical treatment.